| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5714 | 2021 |
| Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... New England Journal of Medicine 384 (20), 1885-1898, 2021 | 1509 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1415 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised … SA Madhi, AL Koen, A Izu, L Fairlie, CL Cutland, V Baillie, ... The Lancet HIV 8 (9), e568-e580, 2021 | 164* | 2021 |
| Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early-and late-onset … SA Madhi, Z Dangor, PT Heath, S Schrag, A Izu, A Sobanjo-ter Meulen, ... Vaccine 31, D52-D57, 2013 | 152 | 2013 |
| Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis A Nanoo, A Izu, NA Ismail, C Ihekweazu, I Abubakar, D Mametja, ... The Lancet infectious diseases 15 (9), 1066-1076, 2015 | 102 | 2015 |
| Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants MC Nunes, CL Cutland, B Dighero, J Bate, S Jones, A Hugo, ... The Journal of infectious diseases 212 (12), 1976-1987, 2015 | 82 | 2015 |
| Potential for maternally administered vaccine for infant group B streptococcus SA Madhi, AS Anderson, J Absalon, D Radley, R Simon, B Jongihlati, ... New England Journal of Medicine 389 (3), 215-227, 2023 | 75 | 2023 |
| Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy OE Simani, A Izu, A Violari, MF Cotton, N Van Niekerk, PV Adrian, ... Aids 28 (4), 531-541, 2014 | 73 | 2014 |
| HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in … Z Dangor, G Kwatra, A Izu, P Adrian, N van Niekerk, CL Cutland, Y Adam, ... The Journal of infectious diseases 212 (3), 453-462, 2015 | 67 | 2015 |
| Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants Z Dangor, G Kwatra, A Izu, P Adrian, CL Cutland, S Velaphi, D Ballot, ... Vaccine 33 (48), 6793-6799, 2015 | 64 | 2015 |
| COVID-19 lockdowns in low-and middle-income countries: Success against COVID-19 at the price of greater costs S A Madhi, G E Gray, N Ismail, A Izu, M Mendelson, N Cassim, W Stevens, ... SAMJ: South African Medical Journal 110 (8), 724-726, 2020 | 63 | 2020 |
| Causes of stillbirths among women from South Africa: a prospective, observational study SA Madhi, C Briner, S Maswime, S Mose, P Mlandu, R Chawana, ... The Lancet Global Health 7 (4), e503-e512, 2019 | 63 | 2019 |
| Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa MJ Groome, ER Zell, F Solomon, S Nzenze, UD Parashar, A Izu, ... Clinical Infectious Diseases 62 (suppl_2), S188-S195, 2016 | 61 | 2016 |
| Predicting prognosis of patients with chronic subdural hematoma: a new scoring system CS Kwon, O Al-Awar, O Richards, A Izu, G Lengvenis World neurosurgery 109, e707-e714, 2018 | 56 | 2018 |
| Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants Z Dangor, G Kwatra, A Izu, SG Lala, SA Madhi Expert review of vaccines 14 (1), 135-149, 2015 | 52 | 2015 |
| Unraveling specific causes of neonatal mortality using minimally invasive tissue sampling: an observational study SA Madhi, J Pathirana, V Baillie, A Izu, Q Bassat, DM Blau, RF Breiman, ... Clinical Infectious Diseases 69 (Supplement_4), S351-S360, 2019 | 51 | 2019 |
| Temporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African children Z Dangor, A Izu, DP Moore, MC Nunes, F Solomon, N Beylis, ... PLoS One 9 (3), e91464, 2014 | 51 | 2014 |
| Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and-uninfected infants SA Madhi, A Izu, A Violari, MF Cotton, R Panchia, E Dobbels, P Sewraj, ... Vaccine 31 (5), 777-783, 2013 | 43 | 2013 |
| All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) compared with the … A Izu, MC Nunes, F Solomon, V Baillie, N Serafin, C Verwey, DP Moore, ... The Lancet Infectious Diseases 23 (9), 1031-1041, 2023 | 42 | 2023 |
